Next Article in Journal
B Cells and Antibodies in Kawasaki Disease
Previous Article in Journal
Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma
Open AccessArticle

A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions

1
Center for Research in Medical Pharmacology, University of Insubria, 21100 Varese (I), Italy
2
Linnea SA, CH-6595 Riazzino, TI (CH), Switzerland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(8), 1833; https://doi.org/10.3390/ijms20081833
Received: 14 March 2019 / Revised: 8 April 2019 / Accepted: 9 April 2019 / Published: 13 April 2019
(This article belongs to the Section Bioactives and Nutraceuticals)
Cannabis and cannabinoids offer significant therapeutic benefits for a wide scope of pathological conditions. Among them, the clinical issues rooted in inflammation stand out, nonetheless, the underlying mechanisms are not yet plainly understood. Circumstantial evidence points to polymorphonuclear leukocytes (PMN) as targets for the anti-inflammatory effects of cannabis. Therefore, we conducted this study to assess the effects of CM5, a novel Cannabis sativa L. extract standardized in 5% cannabidiol (CBD), on human PMN functions, including cell migration, oxidative metabolism and production of tumour necrosis factor (TNF)-α. We then sought to investigate whether such effects could be ascribed to its content in CBD. Cell migration was assessed by the Boyden chamber assay, oxidative metabolism by means of spectrofluorimetric measurement of reactive oxygen species (ROS) production, and TNF-α was measured by real time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). Results show that both CM5 and CBD inhibit PMN migration, ROS and TNF-α production, indicating that CBD may be the main item responsible for the effects of CM5. CM5 is however more potent than CBD on cell migration and TNF-α production, and less effective on ROS production, suggesting that beyond CBD, other components of the cannabis plant may contribute to the biological effects of the extract. As a whole, such results support the use of cannabis standardized extract and CBD to stem inflammation; however, they also warrant in-depth investigation of the underlying cellular and molecular mechanisms to better exploit their therapeutic potential. View Full-Text
Keywords: cannabidiol; cannabis; neutrophils; inflammation; TNF-α; reactive oxygen species; cell migration cannabidiol; cannabis; neutrophils; inflammation; TNF-α; reactive oxygen species; cell migration
Show Figures

Figure 1

MDPI and ACS Style

Mabou Tagne, A.; Marino, F.; Legnaro, M.; Luini, A.; Pacchetti, B.; Cosentino, M. A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions. Int. J. Mol. Sci. 2019, 20, 1833. https://doi.org/10.3390/ijms20081833

AMA Style

Mabou Tagne A, Marino F, Legnaro M, Luini A, Pacchetti B, Cosentino M. A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions. International Journal of Molecular Sciences. 2019; 20(8):1833. https://doi.org/10.3390/ijms20081833

Chicago/Turabian Style

Mabou Tagne, Alex; Marino, Franca; Legnaro, Massimiliano; Luini, Alessandra; Pacchetti, Barbara; Cosentino, Marco. 2019. "A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions" Int. J. Mol. Sci. 20, no. 8: 1833. https://doi.org/10.3390/ijms20081833

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop